Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Allison

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
The American Journal of Gastroenterology|July 17, 2025
Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver DiseaseRichard Parker, Guru Aithal, Michael Allison, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2019
Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitisEwan H Forrest, Natasha Storey, Rohit Sinha, et al.
Clinical and Translational Gastroenterology|October 23, 2020
Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver ImpairmentGiuseppe Ferrandino, Isabel Orf, Rob Smith, et al.
Health Technology Assessment (Winchester, England)|December 23, 2015
The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trialMark Thursz, Ewan Forrest, Paul Roderick, et al.
Genome Biology|June 22, 2018
Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumptionFrancis W B Sanders, Animesh Acharjee, Celia Walker, et al.
Journal of Clinical and Translational Hepatology|March 27, 2023
Breath Biopsy<sup>®</sup> to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis DetectionGiuseppe Ferrandino, Giovanna De Palo, Antonio Murgia, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR studyMaria C van Hooff, Rozanne C de Veer, Vincent Karam, et al.
The New England Journal of Medicine|April 23, 2015
Prednisolone or pentoxifylline for alcoholic hepatitisMark R Thursz, Paul Richardson, Michael Allison, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 23, 2021
The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantationIsabel M A Brüggenwirth, Maureen J M Werner, René Adam, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
The American Journal of Gastroenterology|July 17, 2025
Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver DiseaseRichard Parker, Guru Aithal, Michael Allison, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2019
Baseline neutrophil-to-lymphocyte ratio predicts response to corticosteroids and is associated with infection and renal dysfunction in alcoholic hepatitisEwan H Forrest, Natasha Storey, Rohit Sinha, et al.
Clinical and Translational Gastroenterology|October 23, 2020
Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver ImpairmentGiuseppe Ferrandino, Isabel Orf, Rob Smith, et al.
Health Technology Assessment (Winchester, England)|December 23, 2015
The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trialMark Thursz, Ewan Forrest, Paul Roderick, et al.
Genome Biology|June 22, 2018
Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumptionFrancis W B Sanders, Animesh Acharjee, Celia Walker, et al.
Journal of Clinical and Translational Hepatology|March 27, 2023
Breath Biopsy<sup>®</sup> to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis DetectionGiuseppe Ferrandino, Giovanna De Palo, Antonio Murgia, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis - an ELTR studyMaria C van Hooff, Rozanne C de Veer, Vincent Karam, et al.
The New England Journal of Medicine|April 23, 2015
Prednisolone or pentoxifylline for alcoholic hepatitisMark R Thursz, Paul Richardson, Michael Allison, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 23, 2021
The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantationIsabel M A Brüggenwirth, Maureen J M Werner, René Adam, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
Pageof 10